logo-loader
Cancer Genetics Incorporated

Cancer Genetics shares jump on new loan forbearance agreement

A new loan amendment with Silicon Valley Bank requires the biotech to comply with certain milestones in connection with a potential strategic transaction

blood in vials and cancerous cells
Based in Rutherford, New Jersey, Cancer Genetics offers diagnostic products and services that enable precision medicine in oncology

Shares of Cancer Genetics (NASDAQ:CGIX) are gaining ground in Thursday’s pre-market session thanks to the release of amended terms for a forbearance agreement with its lenders.

According to an 8K regulatory filing with the US Securities and Exchange Commission on Wednesday, the biotech’s new loan amendment with Silicon Valley Bank alters the interest rate to WSJ Prime plus 2.25 percentage points (which means it is 6.75% as of the close of September). It also requires the biotech to comply with certain milestones in connection with a potential strategic transaction.

READ: Cancer Genetics CEO says merger with NovellusDx to speed up enrollment in cancer-focused trials

The company also amended its loan agreement with Partners for Growth, which also outlines milestones for a possible strategic transaction. That loan agreement is an interest-only term loan of $6 million, which bears interest at the rate of 11.5% per year and matures on March 22, 2020.

In response to hints that Cancer Genetics will strike a strategic transaction, investors sent Cancer Genetics shares up 38% to $0.36 before the opening bell on Thursday.

Based in Rutherford, New Jersey, Cancer Genetics offers diagnostic products and services that enable precision medicine in oncology. It boasts clinical research collaborations with key cancer centers such as Memorial Sloan Kettering, The Cleveland Clinic, Mayo Clinic, Keck School of Medicine at USC and the National Cancer Institute.

Contact Ellen Kelleher at [email protected]

Quick facts: Cancer Genetics Incorporated

Price: $0.12

Market: NASDAQ
Market Cap: $6.94 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Empower Clinics begins trading on the OTCQB under the ticker...

Empower Clinics (CSE: CBDT-OTC: EPWCF) Chairman and CEO Steven McAuley sat down with Steve Darling from Proactive Vancouver to share news the company is now trading in the United States. Empower is now listed on the OTCQB market and McAuley talks about what this means for the company and...

50 minutes ago

2 min read